VICTORIA, Sept. 6, 2017 /CNW/ - Emerald Health Therapeutics
Inc. (TSXV: EMH; OCTQX: EMHTF) today announced that Dr. Bin Huang,
President and CEO, will present an overview of the company at the
Rodman & Renshaw 19th Annual Global
Investment Conference.
Presentation:
4:40 PM ET, September 11,
2017
Kennedy II Room
Lotte New York Palace, New York,
NY
Live and archived versions of the presentation will be available
at this link.
Join us on our journey of making lives better through
cannabis science.
Emerald Health Therapeutics Inc.
Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX:EMHTF)
operates primarily through Emerald Health Botanicals Inc.
("Botanicals"), a wholly owned subsidiary of the Company and a
Licensed Producer under the Access to Cannabis for Medical Purposes
Regulations (the "ACMPR"). Botanicals is authorized to produce and
sell both dried medical cannabis flowers and medical cannabis oils
in Canada. Botanicals currently
operates an indoor facility in Victoria,
British Columbia, with plans for expansion on a 32-acre
property in Metro Vancouver and a joint venture with Village Farms
utilizing a 25 acre existing greenhouse complex in Delta, BC. Botanicals is one of Canada's most medically focused licensed
producers, with a team of highly qualified management experienced
in life sciences drug development and large-scale agribusiness.
Emerald's vision is to be a leading provider of cannabis products
through its production capabilities, proprietary genetics and
intellectual property, value-added products and branding, and
superb customer experience. Emerald is part of the Emerald Health
family of companies which is seeking to enhance health and
well-being through diverse investments that advance the development
of cannabis for pharmaceutical, botanical and bioceutical
applications.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Cautionary Statements Regarding Forward Looking
Information
Certain statements in this press release constitute
forward-looking statements, within the meaning of applicable
securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking statements" involve
known and unknown risks and uncertainties that could cause actual
and future events to differ materially from those anticipated in
such statements. Emerald Health Therapeutics Inc. does not intend,
and does not assume any obligation, to update these forward-looking
statements except as required by law.
SOURCE Emerald Health Therapeutics, Inc.